

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 5.30320453 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.30320453 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 4.99782384 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.99782384 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 4.54026121 |
| 6 | alpha-linolenic acid metabolic process (GO:0036109) | 4.42721967 |
| 7 | lysine metabolic process (GO:0006553) | 4.12206481 |
| 8 | lysine catabolic process (GO:0006554) | 4.12206481 |
| 9 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.04395453 |
| 10 | bile acid biosynthetic process (GO:0006699) | 4.00674081 |
| 11 | glyoxylate metabolic process (GO:0046487) | 3.98926712 |
| 12 | cysteine metabolic process (GO:0006534) | 3.95819266 |
| 13 | kynurenine metabolic process (GO:0070189) | 3.88055651 |
| 14 | tryptophan catabolic process (GO:0006569) | 3.83399092 |
| 15 | indole-containing compound catabolic process (GO:0042436) | 3.83399092 |
| 16 | indolalkylamine catabolic process (GO:0046218) | 3.83399092 |
| 17 | glutamate metabolic process (GO:0006536) | 3.78633136 |
| 18 | cellular ketone body metabolic process (GO:0046950) | 3.72040586 |
| 19 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.69807805 |
| 20 | short-chain fatty acid metabolic process (GO:0046459) | 3.64377927 |
| 21 | tryptophan metabolic process (GO:0006568) | 3.64092195 |
| 22 | sulfur amino acid catabolic process (GO:0000098) | 3.62687883 |
| 23 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.61559696 |
| 24 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.49608681 |
| 25 | negative regulation of fibrinolysis (GO:0051918) | 3.44893840 |
| 26 | urea metabolic process (GO:0019627) | 3.44082874 |
| 27 | urea cycle (GO:0000050) | 3.44082874 |
| 28 | homocysteine metabolic process (GO:0050667) | 3.43055571 |
| 29 | bile acid metabolic process (GO:0008206) | 3.41403515 |
| 30 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.38215560 |
| 31 | protein carboxylation (GO:0018214) | 3.38215560 |
| 32 | high-density lipoprotein particle remodeling (GO:0034375) | 3.37588149 |
| 33 | cellular modified amino acid catabolic process (GO:0042219) | 3.36104052 |
| 34 | tyrosine metabolic process (GO:0006570) | 3.35824372 |
| 35 | complement activation, alternative pathway (GO:0006957) | 3.34531849 |
| 36 | aspartate family amino acid catabolic process (GO:0009068) | 3.34524104 |
| 37 | reflex (GO:0060004) | 3.34292895 |
| 38 | neural tube formation (GO:0001841) | 3.32767743 |
| 39 | regulation of protein activation cascade (GO:2000257) | 3.31223196 |
| 40 | ketone body metabolic process (GO:1902224) | 3.30610348 |
| 41 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 3.27640808 |
| 42 | alpha-amino acid catabolic process (GO:1901606) | 3.27635709 |
| 43 | amino-acid betaine metabolic process (GO:0006577) | 3.27369571 |
| 44 | aromatic amino acid family metabolic process (GO:0009072) | 3.24216991 |
| 45 | regulation of fibrinolysis (GO:0051917) | 3.23389337 |
| 46 | drug transmembrane transport (GO:0006855) | 3.22604905 |
| 47 | serine family amino acid catabolic process (GO:0009071) | 3.21609550 |
| 48 | signal peptide processing (GO:0006465) | 3.20970414 |
| 49 | behavioral response to nicotine (GO:0035095) | 3.20438655 |
| 50 | coenzyme catabolic process (GO:0009109) | 3.19681853 |
| 51 | cellular amino acid catabolic process (GO:0009063) | 3.15110921 |
| 52 | nitrogen cycle metabolic process (GO:0071941) | 3.14404338 |
| 53 | regulation of complement activation (GO:0030449) | 3.12236595 |
| 54 | acetyl-CoA metabolic process (GO:0006084) | 3.11581961 |
| 55 | drug catabolic process (GO:0042737) | 3.10730122 |
| 56 | reverse cholesterol transport (GO:0043691) | 3.09300167 |
| 57 | 2-oxoglutarate metabolic process (GO:0006103) | 3.07054816 |
| 58 | presynaptic membrane assembly (GO:0097105) | 3.06425635 |
| 59 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.06242516 |
| 60 | regulation of triglyceride catabolic process (GO:0010896) | 3.05717206 |
| 61 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.05263777 |
| 62 | regulation of hippo signaling (GO:0035330) | 3.02968413 |
| 63 | serotonin metabolic process (GO:0042428) | 3.02794282 |
| 64 | dicarboxylic acid catabolic process (GO:0043649) | 3.01200475 |
| 65 | plasma lipoprotein particle remodeling (GO:0034369) | 2.99966629 |
| 66 | protein-lipid complex remodeling (GO:0034368) | 2.99966629 |
| 67 | macromolecular complex remodeling (GO:0034367) | 2.99966629 |
| 68 | establishment of protein localization to Golgi (GO:0072600) | 2.97530726 |
| 69 | fatty acid beta-oxidation (GO:0006635) | 2.94877804 |
| 70 | acylglycerol homeostasis (GO:0055090) | 2.94292697 |
| 71 | triglyceride homeostasis (GO:0070328) | 2.94292697 |
| 72 | ethanol oxidation (GO:0006069) | 2.94144074 |
| 73 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.92635041 |
| 74 | plasma lipoprotein particle clearance (GO:0034381) | 2.91298038 |
| 75 | cellular glucuronidation (GO:0052695) | 2.91257053 |
| 76 | fatty acid oxidation (GO:0019395) | 2.89467809 |
| 77 | regulation of cholesterol esterification (GO:0010872) | 2.88634801 |
| 78 | primary amino compound metabolic process (GO:1901160) | 2.88417899 |
| 79 | lipid oxidation (GO:0034440) | 2.86138252 |
| 80 | regulation of cholesterol homeostasis (GO:2000188) | 2.82629714 |
| 81 | monocarboxylic acid catabolic process (GO:0072329) | 2.82540217 |
| 82 | negative regulation of cholesterol transport (GO:0032375) | 2.82115417 |
| 83 | negative regulation of sterol transport (GO:0032372) | 2.82115417 |
| 84 | positive regulation of lipid catabolic process (GO:0050996) | 2.80676872 |
| 85 | exogenous drug catabolic process (GO:0042738) | 2.80583543 |
| 86 | presynaptic membrane organization (GO:0097090) | 2.79347734 |
| 87 | organic acid catabolic process (GO:0016054) | 2.79166674 |
| 88 | carboxylic acid catabolic process (GO:0046395) | 2.79166674 |
| 89 | fatty acid catabolic process (GO:0009062) | 2.79090896 |
| 90 | urate metabolic process (GO:0046415) | 2.75056149 |
| 91 | phospholipid homeostasis (GO:0055091) | 2.74964559 |
| 92 | response to mercury ion (GO:0046689) | 2.74041459 |
| 93 | gamma-aminobutyric acid transport (GO:0015812) | 2.73484074 |
| 94 | response to pheromone (GO:0019236) | 2.72808063 |
| 95 | indolalkylamine metabolic process (GO:0006586) | 2.71839337 |
| 96 | benzene-containing compound metabolic process (GO:0042537) | 2.71421688 |
| 97 | negative regulation of lipase activity (GO:0060192) | 2.70847388 |
| 98 | positive regulation of fatty acid oxidation (GO:0046321) | 2.70757726 |
| 99 | phospholipid efflux (GO:0033700) | 2.69975221 |
| 100 | valine metabolic process (GO:0006573) | 2.69695572 |
| 101 | cholesterol efflux (GO:0033344) | 2.69452626 |
| 102 | righting reflex (GO:0060013) | 2.69045289 |
| 103 | inner ear receptor stereocilium organization (GO:0060122) | 2.68204117 |
| 104 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.67921151 |
| 105 | very long-chain fatty acid metabolic process (GO:0000038) | 2.67531547 |
| 106 | cellular response to sterol (GO:0036315) | 2.66585017 |
| 107 | limb development (GO:0060173) | 2.66268756 |
| 108 | appendage development (GO:0048736) | 2.66268756 |
| 109 | nonmotile primary cilium assembly (GO:0035058) | 2.65804594 |
| 110 | bile acid and bile salt transport (GO:0015721) | 2.64785186 |
| 111 | L-fucose catabolic process (GO:0042355) | 2.63427486 |
| 112 | fucose catabolic process (GO:0019317) | 2.63427486 |
| 113 | L-fucose metabolic process (GO:0042354) | 2.63427486 |
| 114 | limb bud formation (GO:0060174) | 2.62797507 |
| 115 | kidney morphogenesis (GO:0060993) | 2.62552228 |
| 116 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.62127842 |
| 117 | negative regulation of neurotransmitter transport (GO:0051589) | 2.62089377 |
| 118 | epoxygenase P450 pathway (GO:0019373) | 2.62014138 |
| 119 | regulation of bile acid biosynthetic process (GO:0070857) | 2.61440520 |
| 120 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.61298331 |
| 121 | low-density lipoprotein particle remodeling (GO:0034374) | 2.60086273 |
| 122 | thyroid hormone metabolic process (GO:0042403) | 2.59587118 |
| 123 | auditory receptor cell stereocilium organization (GO:0060088) | 2.58473956 |
| 124 | glucuronate metabolic process (GO:0019585) | 2.57430496 |
| 125 | uronic acid metabolic process (GO:0006063) | 2.57430496 |
| 126 | photoreceptor cell maintenance (GO:0045494) | 2.57117896 |
| 127 | negative regulation of protein activation cascade (GO:2000258) | 2.55784003 |
| 128 | detection of light stimulus involved in visual perception (GO:0050908) | 2.55303158 |
| 129 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.55303158 |
| 130 | carnitine metabolic process (GO:0009437) | 2.54414781 |
| 131 | epithelial cilium movement (GO:0003351) | 2.54357036 |
| 132 | oxidative demethylation (GO:0070989) | 2.54289423 |
| 133 | fatty acid transmembrane transport (GO:1902001) | 2.53947578 |
| 134 | protein K11-linked deubiquitination (GO:0035871) | 2.53682920 |
| 135 | regulation of cholesterol metabolic process (GO:0090181) | 2.53581810 |
| 136 | transmission of nerve impulse (GO:0019226) | 2.52285498 |
| 137 | cilium morphogenesis (GO:0060271) | 2.52247001 |
| 138 | succinate metabolic process (GO:0006105) | 2.52193420 |
| 139 | regulation of pigment cell differentiation (GO:0050932) | 2.50701724 |
| 140 | magnesium ion transport (GO:0015693) | 2.50499796 |
| 141 | indole-containing compound metabolic process (GO:0042430) | 2.49353597 |
| 142 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.49048037 |
| 143 | proline transport (GO:0015824) | 2.48409397 |
| 144 | serine family amino acid metabolic process (GO:0009069) | 2.48335860 |
| 145 | cilium or flagellum-dependent cell motility (GO:0001539) | 2.47768011 |
| 146 | regulation of cell communication by electrical coupling (GO:0010649) | 2.46846518 |
| 147 | startle response (GO:0001964) | 2.46782929 |
| 148 | regulation of sarcomere organization (GO:0060297) | 2.46497550 |
| 149 | negative regulation of protein localization to cell surface (GO:2000009) | 2.45132673 |
| 150 | embryonic epithelial tube formation (GO:0001838) | 2.43705191 |
| 151 | cilium movement (GO:0003341) | 2.41859422 |
| 152 | cilium organization (GO:0044782) | 2.40416942 |
| 153 | relaxation of cardiac muscle (GO:0055119) | 2.40257738 |
| 154 | protein targeting to Golgi (GO:0000042) | 2.38676152 |
| 155 | cilium assembly (GO:0042384) | 2.36518215 |
| 156 | detection of mechanical stimulus involved in sensory perception (GO:0050974) | 2.35810846 |
| 157 | interkinetic nuclear migration (GO:0022027) | 2.35476496 |
| 158 | dorsal/ventral axis specification (GO:0009950) | 2.33442944 |
| 159 | neuronal action potential (GO:0019228) | 2.32789641 |
| 160 | auditory behavior (GO:0031223) | 2.31042352 |
| 161 | sulfation (GO:0051923) | 2.29814308 |
| 162 | protein targeting to lysosome (GO:0006622) | 2.29784726 |
| 163 | establishment of protein localization to vacuole (GO:0072666) | 2.29784726 |
| 164 | protein targeting to vacuole (GO:0006623) | 2.29784726 |
| 165 | regulation of non-canonical Wnt signaling pathway (GO:2000050) | 2.29605120 |
| 166 | prostate gland growth (GO:0060736) | 2.29588898 |
| 167 | epithelial tube formation (GO:0072175) | 2.28816521 |
| 168 | somite development (GO:0061053) | 2.28131731 |
| 169 | negative regulation of systemic arterial blood pressure (GO:0003085) | 2.28059795 |
| 170 | regulation of mesoderm development (GO:2000380) | 2.27242743 |
| 171 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.26836556 |
| 172 | phospholipid translocation (GO:0045332) | 2.26297926 |
| 173 | lipid translocation (GO:0034204) | 2.26297926 |
| 174 | protein localization to Golgi apparatus (GO:0034067) | 2.25903202 |
| 175 | prenylation (GO:0097354) | 2.24753618 |
| 176 | protein prenylation (GO:0018342) | 2.24753618 |
| 177 | negative regulation of hormone biosynthetic process (GO:0032353) | 2.24460598 |
| 178 | cell morphogenesis involved in neuron differentiation (GO:0048667) | 2.23961291 |
| 179 | regulation of action potential (GO:0098900) | 2.22948118 |
| 180 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.22854486 |
| 181 | regulation of neurotransmitter uptake (GO:0051580) | 2.22372538 |
| 182 | microtubule anchoring (GO:0034453) | 2.22276991 |
| 183 | negative regulation of sodium ion transport (GO:0010766) | 2.21132288 |
| 184 | negative regulation of astrocyte differentiation (GO:0048712) | 2.20939334 |
| 185 | vascular smooth muscle contraction (GO:0014829) | 2.20537718 |
| 186 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.19958025 |
| 187 | behavioral response to ethanol (GO:0048149) | 2.19845982 |
| 188 | positive regulation of cardiac muscle cell differentiation (GO:2000727) | 2.19267867 |
| 189 | central nervous system myelination (GO:0022010) | 2.19214026 |
| 190 | axon ensheathment in central nervous system (GO:0032291) | 2.19214026 |
| 191 | glycosphingolipid biosynthetic process (GO:0006688) | 2.19094779 |
| 192 | protein localization to cilium (GO:0061512) | 2.19077868 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.74078407 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.17954074 |
| 3 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.51646983 |
| 4 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.36871389 |
| 5 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.89502019 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.86862702 |
| 7 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.82490250 |
| 8 | * FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.69075005 |
| 9 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.56252054 |
| 10 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.56099042 |
| 11 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.52574142 |
| 12 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.20808236 |
| 13 | FUS_26573619_Chip-Seq_HEK293_Human | 2.14512868 |
| 14 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.08764663 |
| 15 | VDR_22108803_ChIP-Seq_LS180_Human | 2.05457138 |
| 16 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.02558574 |
| 17 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.97630277 |
| 18 | EWS_26573619_Chip-Seq_HEK293_Human | 1.92373563 |
| 19 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.85423680 |
| 20 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.84896349 |
| 21 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.73153268 |
| 22 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.70332775 |
| 23 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.68342936 |
| 24 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.63714874 |
| 25 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.60506258 |
| 26 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.59829799 |
| 27 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.58982133 |
| 28 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.55875849 |
| 29 | TCF4_23295773_ChIP-Seq_U87_Human | 1.55333454 |
| 30 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.51941827 |
| 31 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.50998443 |
| 32 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.50363970 |
| 33 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.49934390 |
| 34 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.49885376 |
| 35 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.49885376 |
| 36 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.48070204 |
| 37 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.47617942 |
| 38 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.46576494 |
| 39 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.45768643 |
| 40 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.44886980 |
| 41 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.43808225 |
| 42 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.43808225 |
| 43 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.43702224 |
| 44 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.43227651 |
| 45 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.40848831 |
| 46 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.39916746 |
| 47 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.39489957 |
| 48 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.38670218 |
| 49 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.38670218 |
| 50 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.38643689 |
| 51 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.37638459 |
| 52 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.37399658 |
| 53 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.36949546 |
| 54 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.36464833 |
| 55 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.35603299 |
| 56 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.33035197 |
| 57 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.32878914 |
| 58 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.32825471 |
| 59 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.32574691 |
| 60 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.32219876 |
| 61 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.31969117 |
| 62 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.31269994 |
| 63 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.30823592 |
| 64 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.30380561 |
| 65 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.30035882 |
| 66 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.29536742 |
| 67 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.29440453 |
| 68 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.28921431 |
| 69 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.26373925 |
| 70 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 1.26231832 |
| 71 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.25117604 |
| 72 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.24269811 |
| 73 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.22682050 |
| 74 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.22680497 |
| 75 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.21826113 |
| 76 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.21723140 |
| 77 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.19632146 |
| 78 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.18651366 |
| 79 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.17004713 |
| 80 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.16883152 |
| 81 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.16877670 |
| 82 | CJUN_26792858_Chip-Seq_BT549_Human | 1.16518344 |
| 83 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.15485159 |
| 84 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.15118943 |
| 85 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.14950601 |
| 86 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.13250689 |
| 87 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.12423093 |
| 88 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.12182414 |
| 89 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.11983092 |
| 90 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.11891746 |
| 91 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.11787184 |
| 92 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.11787184 |
| 93 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.11765528 |
| 94 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.11753907 |
| 95 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.11598462 |
| 96 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.11449962 |
| 97 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.10708682 |
| 98 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.10708682 |
| 99 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.10499795 |
| 100 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.10055788 |
| 101 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.09874102 |
| 102 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.09331748 |
| 103 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.09209119 |
| 104 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.08793307 |
| 105 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.07626975 |
| 106 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.07532095 |
| 107 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.07485028 |
| 108 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.06799556 |
| 109 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.06680966 |
| 110 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.06236205 |
| 111 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.05953851 |
| 112 | * TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.05878310 |
| 113 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.05402987 |
| 114 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.05299414 |
| 115 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.03243016 |
| 116 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.02873156 |
| 117 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.02170034 |
| 118 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.00839239 |
| 119 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.00512337 |
| 120 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.99770549 |
| 121 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.98317356 |
| 122 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.98165139 |
| 123 | GATA1_22025678_ChIP-Seq_K562_Human | 0.98157754 |
| 124 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.97365499 |
| 125 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.96373823 |
| 126 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.96120250 |
| 127 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.95751613 |
| 128 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.95428416 |
| 129 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.95406253 |
| 130 | TP53_16413492_ChIP-PET_HCT116_Human | 0.95187308 |
| 131 | REST_21632747_ChIP-Seq_MESCs_Mouse | 0.95057270 |
| 132 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.94299393 |
| 133 | RXR_22108803_ChIP-Seq_LS180_Human | 0.94278111 |
| 134 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.93859101 |
| 135 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.93237355 |
| 136 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.92374668 |
| 137 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.92306604 |
| 138 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.91419381 |
| 139 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.90686718 |
| 140 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.90671454 |
| 141 | AR_25329375_ChIP-Seq_VCAP_Human | 0.88531040 |
| 142 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.88329940 |
| 143 | STAT3_23295773_ChIP-Seq_U87_Human | 0.87940202 |
| 144 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.87655649 |
| 145 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.87476213 |
| 146 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.84943774 |
| 147 | AR_19668381_ChIP-Seq_PC3_Human | 0.84895881 |
| 148 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.84865865 |
| 149 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.84733738 |
| 150 | * P300_19829295_ChIP-Seq_ESCs_Human | 0.84685067 |
| 151 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.82558734 |
| 152 | * CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.82518622 |
| 153 | * CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.81983615 |
| 154 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.81280313 |
| 155 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.81204720 |
| 156 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.79726584 |
| 157 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.78147387 |
| 158 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.78030016 |
| 159 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.74934059 |
| 160 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.73683524 |
| 161 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.73683524 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 5.96166738 |
| 2 | MP0005360_urolithiasis | 5.71414376 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 4.53086771 |
| 4 | MP0005365_abnormal_bile_salt | 4.35792049 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 3.67583629 |
| 6 | MP0000569_abnormal_digit_pigmentation | 3.28158392 |
| 7 | MP0003252_abnormal_bile_duct | 3.24414552 |
| 8 | MP0003195_calcinosis | 2.92260879 |
| 9 | MP0010329_abnormal_lipoprotein_level | 2.70491168 |
| 10 | MP0005332_abnormal_amino_acid | 2.67968008 |
| 11 | MP0004859_abnormal_synaptic_plasticity | 2.26962370 |
| 12 | MP0001984_abnormal_olfaction | 2.25171486 |
| 13 | MP0003806_abnormal_nucleotide_metabolis | 2.11499821 |
| 14 | MP0005083_abnormal_biliary_tract | 2.03514877 |
| 15 | MP0005551_abnormal_eye_electrophysiolog | 1.99393724 |
| 16 | MP0010386_abnormal_urinary_bladder | 1.92146638 |
| 17 | MP0001666_abnormal_nutrient_absorption | 1.91643935 |
| 18 | MP0005171_absent_coat_pigmentation | 1.90371146 |
| 19 | MP0002118_abnormal_lipid_homeostasis | 1.87635914 |
| 20 | MP0002638_abnormal_pupillary_reflex | 1.86476072 |
| 21 | MP0003329_amyloid_beta_deposits | 1.82567469 |
| 22 | MP0009840_abnormal_foam_cell | 1.82528039 |
| 23 | MP0004043_abnormal_pH_regulation | 1.82383850 |
| 24 | MP0002102_abnormal_ear_morphology | 1.80258398 |
| 25 | MP0009780_abnormal_chondrocyte_physiolo | 1.77776367 |
| 26 | MP0000383_abnormal_hair_follicle | 1.76695308 |
| 27 | MP0004215_abnormal_myocardial_fiber | 1.70501796 |
| 28 | MP0004019_abnormal_vitamin_homeostasis | 1.70328001 |
| 29 | MP0003690_abnormal_glial_cell | 1.64021979 |
| 30 | MP0003136_yellow_coat_color | 1.62261984 |
| 31 | MP0004130_abnormal_muscle_cell | 1.61910623 |
| 32 | MP0006072_abnormal_retinal_apoptosis | 1.60272913 |
| 33 | MP0005253_abnormal_eye_physiology | 1.58504693 |
| 34 | MP0010678_abnormal_skin_adnexa | 1.56919553 |
| 35 | MP0000427_abnormal_hair_cycle | 1.54870145 |
| 36 | MP0004145_abnormal_muscle_electrophysio | 1.53393773 |
| 37 | MP0003646_muscle_fatigue | 1.50726936 |
| 38 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.48737826 |
| 39 | MP0002138_abnormal_hepatobiliary_system | 1.48245154 |
| 40 | MP0000604_amyloidosis | 1.46405363 |
| 41 | MP0002822_catalepsy | 1.44406486 |
| 42 | MP0002837_dystrophic_cardiac_calcinosis | 1.44337813 |
| 43 | MP0003191_abnormal_cellular_cholesterol | 1.44178516 |
| 44 | MP0003868_abnormal_feces_composition | 1.40365766 |
| 45 | MP0005187_abnormal_penis_morphology | 1.39102088 |
| 46 | MP0003635_abnormal_synaptic_transmissio | 1.39084630 |
| 47 | MP0008877_abnormal_DNA_methylation | 1.38807696 |
| 48 | MP0006276_abnormal_autonomic_nervous | 1.38418056 |
| 49 | MP0001485_abnormal_pinna_reflex | 1.37679123 |
| 50 | MP0000609_abnormal_liver_physiology | 1.37394642 |
| 51 | MP0002736_abnormal_nociception_after | 1.36139744 |
| 52 | MP0010234_abnormal_vibrissa_follicle | 1.33556311 |
| 53 | MP0004270_analgesia | 1.32867348 |
| 54 | MP0002938_white_spotting | 1.32853546 |
| 55 | MP0000631_abnormal_neuroendocrine_gland | 1.32604378 |
| 56 | MP0004147_increased_porphyrin_level | 1.32216427 |
| 57 | MP0004142_abnormal_muscle_tone | 1.31623817 |
| 58 | MP0008057_abnormal_DNA_replication | 1.31005223 |
| 59 | MP0003937_abnormal_limbs/digits/tail_de | 1.28487405 |
| 60 | MP0009643_abnormal_urine_homeostasis | 1.27966373 |
| 61 | MP0004885_abnormal_endolymph | 1.27535096 |
| 62 | MP0000778_abnormal_nervous_system | 1.27095286 |
| 63 | MP0003705_abnormal_hypodermis_morpholog | 1.24242294 |
| 64 | MP0003787_abnormal_imprinting | 1.23609779 |
| 65 | MP0000013_abnormal_adipose_tissue | 1.22395014 |
| 66 | MP0005319_abnormal_enzyme/_coenzyme | 1.22302173 |
| 67 | MP0003890_abnormal_embryonic-extraembry | 1.20841807 |
| 68 | MP0005535_abnormal_body_temperature | 1.18827887 |
| 69 | MP0009745_abnormal_behavioral_response | 1.17992436 |
| 70 | MP0003283_abnormal_digestive_organ | 1.17647215 |
| 71 | MP0002064_seizures | 1.17027843 |
| 72 | MP0002557_abnormal_social/conspecific_i | 1.15696791 |
| 73 | MP0005174_abnormal_tail_pigmentation | 1.12938001 |
| 74 | MP0004134_abnormal_chest_morphology | 1.12457866 |
| 75 | MP0002735_abnormal_chemical_nociception | 1.09869174 |
| 76 | MP0003633_abnormal_nervous_system | 1.09833997 |
| 77 | MP0002063_abnormal_learning/memory/cond | 1.07696226 |
| 78 | MP0002009_preneoplasia | 1.07612156 |
| 79 | MP0002909_abnormal_adrenal_gland | 1.07244030 |
| 80 | MP0000647_abnormal_sebaceous_gland | 1.04524116 |
| 81 | MP0002184_abnormal_innervation | 1.03971889 |
| 82 | MP0000920_abnormal_myelination | 1.03465374 |
| 83 | MP0005645_abnormal_hypothalamus_physiol | 1.03169879 |
| 84 | MP0002160_abnormal_reproductive_system | 1.03028942 |
| 85 | MP0001756_abnormal_urination | 1.01917191 |
| 86 | MP0008775_abnormal_heart_ventricle | 1.01417482 |
| 87 | MP0003119_abnormal_digestive_system | 1.01218576 |
| 88 | MP0003880_abnormal_central_pattern | 0.99134737 |
| 89 | MP0002234_abnormal_pharynx_morphology | 0.98855863 |
| 90 | MP0004484_altered_response_of | 0.98642298 |
| 91 | MP0004085_abnormal_heartbeat | 0.98157888 |
| 92 | MP0002078_abnormal_glucose_homeostasis | 0.97568906 |
| 93 | MP0005670_abnormal_white_adipose | 0.97458937 |
| 94 | MP0002067_abnormal_sensory_capabilities | 0.97458765 |
| 95 | MP0009046_muscle_twitch | 0.96799262 |
| 96 | MP0009384_cardiac_valve_regurgitation | 0.96172043 |
| 97 | MP0004084_abnormal_cardiac_muscle | 0.95982652 |
| 98 | MP0008438_abnormal_cutaneous_collagen | 0.95157698 |
| 99 | MP0001765_abnormal_ion_homeostasis | 0.93908429 |
| 100 | MP0001502_abnormal_circadian_rhythm | 0.93518117 |
| 101 | MP0000538_abnormal_urinary_bladder | 0.93075814 |
| 102 | MP0001486_abnormal_startle_reflex | 0.93040822 |
| 103 | MP0003137_abnormal_impulse_conducting | 0.92167305 |
| 104 | MP0008872_abnormal_physiological_respon | 0.90818655 |
| 105 | MP0005666_abnormal_adipose_tissue | 0.90817241 |
| 106 | MP0002971_abnormal_brown_adipose | 0.90384132 |
| 107 | MP0004133_heterotaxia | 0.89391959 |
| 108 | MP0002090_abnormal_vision | 0.88915764 |
| 109 | MP0005636_abnormal_mineral_homeostasis | 0.86769407 |
| 110 | MP0005195_abnormal_posterior_eye | 0.85807395 |
| 111 | MP0001970_abnormal_pain_threshold | 0.85760597 |
| 112 | MP0002272_abnormal_nervous_system | 0.84905744 |
| 113 | MP0000026_abnormal_inner_ear | 0.84172344 |
| 114 | MP0003300_gastrointestinal_ulcer | 0.83381395 |
| 115 | MP0003075_altered_response_to | 0.82801823 |
| 116 | MP0003631_nervous_system_phenotype | 0.82229081 |
| 117 | MP0000955_abnormal_spinal_cord | 0.82126143 |
| 118 | MP0005248_abnormal_Harderian_gland | 0.81772576 |
| 119 | MP0003011_delayed_dark_adaptation | 0.81737474 |
| 120 | MP0001661_extended_life_span | 0.81635605 |
| 121 | MP0002572_abnormal_emotion/affect_behav | 0.81332888 |
| 122 | MP0005167_abnormal_blood-brain_barrier | 0.81081314 |
| 123 | MP0002233_abnormal_nose_morphology | 0.80630144 |
| 124 | MP0005084_abnormal_gallbladder_morpholo | 0.80138700 |
| 125 | MP0001764_abnormal_homeostasis | 0.79974891 |
| 126 | MP0003950_abnormal_plasma_membrane | 0.79434108 |
| 127 | MP0008874_decreased_physiological_sensi | 0.79341028 |
| 128 | MP0000230_abnormal_systemic_arterial | 0.78837022 |
| 129 | MP0001299_abnormal_eye_distance/ | 0.78351840 |
| 130 | MP0002752_abnormal_somatic_nervous | 0.78141405 |
| 131 | MP0003122_maternal_imprinting | 0.78043996 |
| 132 | MP0005423_abnormal_somatic_nervous | 0.77685096 |
| 133 | MP0001177_atelectasis | 0.76006653 |
| 134 | MP0002254_reproductive_system_inflammat | 0.75016641 |
| 135 | MP0008961_abnormal_basal_metabolism | 0.74559722 |
| 136 | MP0005058_abnormal_lysosome_morphology | 0.73581077 |
| 137 | MP0004858_abnormal_nervous_system | 0.73208349 |
| 138 | MP0002876_abnormal_thyroid_physiology | 0.72845367 |
| 139 | MP0001440_abnormal_grooming_behavior | 0.70990984 |
| 140 | MP0005334_abnormal_fat_pad | 0.70948159 |
| 141 | MP0002168_other_aberrant_phenotype | 0.69881560 |
| 142 | MP0001501_abnormal_sleep_pattern | 0.69792222 |
| 143 | MP0005375_adipose_tissue_phenotype | 0.69050948 |
| 144 | MP0010368_abnormal_lymphatic_system | 0.68959636 |
| 145 | MP0000003_abnormal_adipose_tissue | 0.65846745 |
| 146 | MP0000747_muscle_weakness | 0.65091330 |
| 147 | MP0005647_abnormal_sex_gland | 0.64646378 |
| 148 | MP0004924_abnormal_behavior | 0.63718654 |
| 149 | MP0005386_behavior/neurological_phenoty | 0.63718654 |
| 150 | MP0002734_abnormal_mechanical_nocicepti | 0.62660164 |
| 151 | MP0003632_abnormal_nervous_system | 0.62534702 |
| 152 | MP0002295_abnormal_pulmonary_circulatio | 0.62061432 |
| 153 | MP0004036_abnormal_muscle_relaxation | 0.60810076 |
| 154 | MP0009642_abnormal_blood_homeostasis | 0.60615982 |
| 155 | MP0004185_abnormal_adipocyte_glucose | 0.59686491 |
| 156 | MP0000639_abnormal_adrenal_gland | 0.59560506 |
| 157 | MP0005448_abnormal_energy_balance | 0.59497116 |
| 158 | MP0008569_lethality_at_weaning | 0.58910602 |
| 159 | MP0001968_abnormal_touch/_nociception | 0.58850902 |
| 160 | MP0003634_abnormal_glial_cell | 0.58300364 |
| 161 | MP0005646_abnormal_pituitary_gland | 0.57685935 |
| 162 | MP0002069_abnormal_eating/drinking_beha | 0.56989423 |
| 163 | MP0003656_abnormal_erythrocyte_physiolo | 0.56887288 |
| 164 | MP0002928_abnormal_bile_duct | 0.56867077 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 5.14250193 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.01564071 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 4.81243069 |
| 4 | Xanthomatosis (HP:0000991) | 4.70540915 |
| 5 | Pancreatic cysts (HP:0001737) | 4.19694188 |
| 6 | Hyperlipoproteinemia (HP:0010980) | 4.07877720 |
| 7 | Ketosis (HP:0001946) | 3.99916412 |
| 8 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.95777197 |
| 9 | Pancreatic fibrosis (HP:0100732) | 3.79957243 |
| 10 | True hermaphroditism (HP:0010459) | 3.73947225 |
| 11 | Ketoacidosis (HP:0001993) | 3.71104604 |
| 12 | Prolonged partial thromboplastin time (HP:0003645) | 3.65573895 |
| 13 | Complement deficiency (HP:0004431) | 3.59588096 |
| 14 | Hyperammonemia (HP:0001987) | 3.53879006 |
| 15 | Hypobetalipoproteinemia (HP:0003563) | 3.52641253 |
| 16 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.43846936 |
| 17 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.40102769 |
| 18 | Abnormality of glycine metabolism (HP:0010895) | 3.40102769 |
| 19 | Hyperglycinuria (HP:0003108) | 3.37260939 |
| 20 | Hyperglycinemia (HP:0002154) | 3.37008140 |
| 21 | Hypoglycemic coma (HP:0001325) | 3.35023385 |
| 22 | Medial flaring of the eyebrow (HP:0010747) | 3.34911023 |
| 23 | Abnormality of the renal cortex (HP:0011035) | 3.34416232 |
| 24 | Gaze-evoked nystagmus (HP:0000640) | 3.25418306 |
| 25 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 3.24481002 |
| 26 | Genetic anticipation (HP:0003743) | 3.24119633 |
| 27 | Gout (HP:0001997) | 3.23091602 |
| 28 | Epidermoid cyst (HP:0200040) | 3.19406905 |
| 29 | Hypoalphalipoproteinemia (HP:0003233) | 3.17892977 |
| 30 | Hypolipoproteinemia (HP:0010981) | 3.09405085 |
| 31 | Abnormality of midbrain morphology (HP:0002418) | 3.06076864 |
| 32 | Molar tooth sign on MRI (HP:0002419) | 3.06076864 |
| 33 | Nephronophthisis (HP:0000090) | 3.03834145 |
| 34 | Abnormality of the common coagulation pathway (HP:0010990) | 2.96584716 |
| 35 | Abnormality of the renal medulla (HP:0100957) | 2.95845733 |
| 36 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.93253841 |
| 37 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.92175686 |
| 38 | Gait imbalance (HP:0002141) | 2.90498652 |
| 39 | Genital tract atresia (HP:0001827) | 2.83621173 |
| 40 | Congenital primary aphakia (HP:0007707) | 2.83596222 |
| 41 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.83015956 |
| 42 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.82589187 |
| 43 | Febrile seizures (HP:0002373) | 2.80767372 |
| 44 | Renal cortical cysts (HP:0000803) | 2.76130423 |
| 45 | Progressive cerebellar ataxia (HP:0002073) | 2.74868980 |
| 46 | Vaginal atresia (HP:0000148) | 2.72018924 |
| 47 | Neurofibrillary tangles (HP:0002185) | 2.70752263 |
| 48 | Cystic liver disease (HP:0006706) | 2.66764003 |
| 49 | Tubular atrophy (HP:0000092) | 2.65415846 |
| 50 | Abnormality of purine metabolism (HP:0004352) | 2.60893704 |
| 51 | Increased corneal curvature (HP:0100692) | 2.60490388 |
| 52 | Keratoconus (HP:0000563) | 2.60490388 |
| 53 | Fat malabsorption (HP:0002630) | 2.60082088 |
| 54 | Skin nodule (HP:0200036) | 2.59051108 |
| 55 | Chronic hepatic failure (HP:0100626) | 2.57070774 |
| 56 | Large for gestational age (HP:0001520) | 2.54777606 |
| 57 | Nephrogenic diabetes insipidus (HP:0009806) | 2.54084287 |
| 58 | Delayed CNS myelination (HP:0002188) | 2.50456621 |
| 59 | Abnormality of methionine metabolism (HP:0010901) | 2.48828458 |
| 60 | Joint hemorrhage (HP:0005261) | 2.48636745 |
| 61 | Hypokalemic alkalosis (HP:0001949) | 2.46965252 |
| 62 | Cerebral inclusion bodies (HP:0100314) | 2.46611439 |
| 63 | Increased circulating renin level (HP:0000848) | 2.44354038 |
| 64 | Fair hair (HP:0002286) | 2.42520192 |
| 65 | Hemiparesis (HP:0001269) | 2.42514617 |
| 66 | Hypercholesterolemia (HP:0003124) | 2.40276496 |
| 67 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.37018998 |
| 68 | Abnormality of the intrinsic pathway (HP:0010989) | 2.36866059 |
| 69 | Alkalosis (HP:0001948) | 2.35590789 |
| 70 | Conjugated hyperbilirubinemia (HP:0002908) | 2.35294694 |
| 71 | Short tibia (HP:0005736) | 2.34117483 |
| 72 | Abolished electroretinogram (ERG) (HP:0000550) | 2.32948542 |
| 73 | Abnormality of the ischium (HP:0003174) | 2.31864386 |
| 74 | Abnormality of complement system (HP:0005339) | 2.30205880 |
| 75 | Mitral stenosis (HP:0001718) | 2.30198037 |
| 76 | Chorioretinal atrophy (HP:0000533) | 2.30156734 |
| 77 | Sensorimotor neuropathy (HP:0007141) | 2.29629694 |
| 78 | Congenital sensorineural hearing impairment (HP:0008527) | 2.29278749 |
| 79 | Hyperventilation (HP:0002883) | 2.29085027 |
| 80 | Hypothermia (HP:0002045) | 2.27118035 |
| 81 | Hypoglycemic seizures (HP:0002173) | 2.26921192 |
| 82 | Status epilepticus (HP:0002133) | 2.24846644 |
| 83 | Metabolic alkalosis (HP:0200114) | 2.22186639 |
| 84 | Furrowed tongue (HP:0000221) | 2.20309800 |
| 85 | Congenital stationary night blindness (HP:0007642) | 2.18902982 |
| 86 | Decreased circulating renin level (HP:0003351) | 2.18423679 |
| 87 | Poor coordination (HP:0002370) | 2.18119784 |
| 88 | Hyperuricemia (HP:0002149) | 2.18049308 |
| 89 | Increased purine levels (HP:0004368) | 2.18049308 |
| 90 | Type II lissencephaly (HP:0007260) | 2.16679218 |
| 91 | Focal motor seizures (HP:0011153) | 2.14645537 |
| 92 | Metabolic acidosis (HP:0001942) | 2.12846103 |
| 93 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 2.10435055 |
| 94 | Intention tremor (HP:0002080) | 2.10117722 |
| 95 | Hepatocellular carcinoma (HP:0001402) | 2.09996782 |
| 96 | Vascular calcification (HP:0004934) | 2.09560548 |
| 97 | Attenuation of retinal blood vessels (HP:0007843) | 2.09329405 |
| 98 | Hyperbilirubinemia (HP:0002904) | 2.08464472 |
| 99 | Abnormality of the nasal septum (HP:0000419) | 2.08335794 |
| 100 | Turricephaly (HP:0000262) | 2.08159547 |
| 101 | Postaxial foot polydactyly (HP:0001830) | 2.07871810 |
| 102 | Broad-based gait (HP:0002136) | 2.07841177 |
| 103 | Cerebellar dysplasia (HP:0007033) | 2.07439361 |
| 104 | Abnormality of nucleobase metabolism (HP:0010932) | 2.06256432 |
| 105 | Preaxial foot polydactyly (HP:0001841) | 2.06127699 |
| 106 | Myocardial infarction (HP:0001658) | 2.05808047 |
| 107 | Male pseudohermaphroditism (HP:0000037) | 2.05597890 |
| 108 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.05570521 |
| 109 | Drooling (HP:0002307) | 2.05004601 |
| 110 | Cardiovascular calcification (HP:0011915) | 2.04038288 |
| 111 | Abnormality of proline metabolism (HP:0010907) | 2.03467743 |
| 112 | Hydroxyprolinuria (HP:0003080) | 2.03467743 |
| 113 | Action tremor (HP:0002345) | 2.03248803 |
| 114 | Progressive inability to walk (HP:0002505) | 2.03136351 |
| 115 | Neonatal onset (HP:0003623) | 2.02620739 |
| 116 | Abnormality of serum amino acid levels (HP:0003112) | 2.01800768 |
| 117 | Abnormal drinking behavior (HP:0030082) | 2.00814473 |
| 118 | Polydipsia (HP:0001959) | 2.00814473 |
| 119 | Cutaneous finger syndactyly (HP:0010554) | 1.99909588 |
| 120 | Postaxial hand polydactyly (HP:0001162) | 1.99296231 |
| 121 | Myokymia (HP:0002411) | 1.97986820 |
| 122 | Short foot (HP:0001773) | 1.97653815 |
| 123 | Protruding tongue (HP:0010808) | 1.97213146 |
| 124 | Generalized hypopigmentation of hair (HP:0011358) | 1.95649751 |
| 125 | Hypoplastic ischia (HP:0003175) | 1.95023347 |
| 126 | Short hallux (HP:0010109) | 1.94799629 |
| 127 | Absent speech (HP:0001344) | 1.94606370 |
| 128 | Dicarboxylic aciduria (HP:0003215) | 1.93784772 |
| 129 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.93784772 |
| 130 | Inability to walk (HP:0002540) | 1.93746380 |
| 131 | Spastic diplegia (HP:0001264) | 1.93652074 |
| 132 | Irritability (HP:0000737) | 1.92945895 |
| 133 | Congenital hepatic fibrosis (HP:0002612) | 1.90051708 |
| 134 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 1.90015896 |
| 135 | Abnormality of the Achilles tendon (HP:0005109) | 1.89374807 |
| 136 | Abnormal gallbladder morphology (HP:0012437) | 1.88513754 |
| 137 | Dialeptic seizures (HP:0011146) | 1.85467610 |
| 138 | Hyperaldosteronism (HP:0000859) | 1.83967530 |
| 139 | Torticollis (HP:0000473) | 1.83514905 |
| 140 | Cholelithiasis (HP:0001081) | 1.82849219 |
| 141 | Abnormality of alanine metabolism (HP:0010916) | 1.81717546 |
| 142 | Hyperalaninemia (HP:0003348) | 1.81717546 |
| 143 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.81717546 |
| 144 | Generalized aminoaciduria (HP:0002909) | 1.80867678 |
| 145 | Amyloidosis (HP:0011034) | 1.79781100 |
| 146 | Specific learning disability (HP:0001328) | 1.77785662 |
| 147 | Abnormality of renin-angiotensin system (HP:0000847) | 1.77108098 |
| 148 | Confusion (HP:0001289) | 1.76949387 |
| 149 | Steatorrhea (HP:0002570) | 1.76351369 |
| 150 | Proximal tubulopathy (HP:0000114) | 1.75493312 |
| 151 | Abnormal ciliary motility (HP:0012262) | 1.75095546 |
| 152 | Hypoplastic labia majora (HP:0000059) | 1.74787984 |
| 153 | Abnormality of secondary sexual hair (HP:0009888) | 1.74565014 |
| 154 | Abnormality of the axillary hair (HP:0100134) | 1.74565014 |
| 155 | Thyroid-stimulating hormone excess (HP:0002925) | 1.74182564 |
| 156 | Excessive salivation (HP:0003781) | 1.74164757 |
| 157 | Lethargy (HP:0001254) | 1.74161172 |
| 158 | Vomiting (HP:0002013) | 1.73269387 |
| 159 | Spontaneous abortion (HP:0005268) | 1.73154591 |
| 160 | Back pain (HP:0003418) | 1.73137576 |
| 161 | Termporal pattern (HP:0011008) | 1.72731841 |
| 162 | Insidious onset (HP:0003587) | 1.72731841 |
| 163 | Widely spaced teeth (HP:0000687) | 1.72078908 |
| 164 | Scanning speech (HP:0002168) | 1.71816491 |
| 165 | Enlarged kidneys (HP:0000105) | 1.71573381 |
| 166 | Abnormal gallbladder physiology (HP:0012438) | 1.70823095 |
| 167 | Cholecystitis (HP:0001082) | 1.70823095 |
| 168 | Focal seizures (HP:0007359) | 1.70791729 |
| 169 | Blue irides (HP:0000635) | 1.70276891 |
| 170 | Myoglobinuria (HP:0002913) | 1.69990793 |
| 171 | Hyperglycemia (HP:0003074) | 1.69555820 |
| 172 | Craniofacial dystonia (HP:0012179) | 1.69209721 |
| 173 | Sclerocornea (HP:0000647) | 1.68745318 |
| 174 | Lymphangioma (HP:0100764) | 1.68679019 |
| 175 | Abnormal biliary tract morphology (HP:0012440) | 1.68546778 |
| 176 | Abnormality of macular pigmentation (HP:0008002) | 1.67894088 |
| 177 | Long nose (HP:0003189) | 1.67708316 |
| 178 | Pheochromocytoma (HP:0002666) | 1.66889775 |
| 179 | Hyperactive renin-angiotensin system (HP:0000841) | 1.66123783 |
| 180 | Focal dystonia (HP:0004373) | 1.65536045 |
| 181 | Congenital, generalized hypertrichosis (HP:0004540) | 1.65479462 |
| 182 | Aplasia/Hypoplasia of the fibula (HP:0006492) | 1.64638268 |
| 183 | Cerebral hemorrhage (HP:0001342) | 1.64459736 |
| 184 | Atonic seizures (HP:0010819) | 1.63822210 |
| 185 | Hypokalemia (HP:0002900) | 1.62185580 |
| 186 | Abnormality of the labia majora (HP:0012881) | 1.61228611 |
| 187 | Aplasia/Hypoplasia of the phalanges of the toes (HP:0010173) | 1.61168263 |
| 188 | Polyuria (HP:0000103) | 1.60277565 |
| 189 | Absent/shortened dynein arms (HP:0200106) | 1.59205196 |
| 190 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.59205196 |
| 191 | Clumsiness (HP:0002312) | 1.58948743 |
| 192 | Calf muscle hypertrophy (HP:0008981) | 1.58826577 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 2.66368802 |
| 2 | ACVR1B | 2.63809064 |
| 3 | CASK | 2.59192768 |
| 4 | BMPR1B | 2.44661022 |
| 5 | BCKDK | 2.44493999 |
| 6 | OXSR1 | 2.29996180 |
| 7 | FRK | 2.25097183 |
| 8 | NTRK3 | 2.24487316 |
| 9 | SIK1 | 2.23887989 |
| 10 | WNK4 | 2.23170948 |
| 11 | FGFR2 | 2.16892615 |
| 12 | STK38L | 1.92374795 |
| 13 | INSRR | 1.91860025 |
| 14 | ERBB3 | 1.90206433 |
| 15 | TRIB3 | 1.89817863 |
| 16 | STK39 | 1.88766042 |
| 17 | MAP2K4 | 1.83810175 |
| 18 | NTRK1 | 1.82526214 |
| 19 | AKT3 | 1.79721450 |
| 20 | MAP3K9 | 1.78551582 |
| 21 | GRK1 | 1.77968656 |
| 22 | DAPK2 | 1.77576529 |
| 23 | ADRBK2 | 1.75318496 |
| 24 | WNK3 | 1.74526526 |
| 25 | KSR2 | 1.67907389 |
| 26 | MAP3K4 | 1.67368573 |
| 27 | MAP4K2 | 1.66710785 |
| 28 | TNIK | 1.63754385 |
| 29 | MAPK13 | 1.55255093 |
| 30 | PAK3 | 1.45830419 |
| 31 | PRKD3 | 1.45817258 |
| 32 | BCR | 1.41120493 |
| 33 | MAP3K2 | 1.40231384 |
| 34 | PAK6 | 1.36409679 |
| 35 | OBSCN | 1.34760566 |
| 36 | FGFR4 | 1.34517278 |
| 37 | CAMKK1 | 1.34104571 |
| 38 | SGK223 | 1.33833084 |
| 39 | SGK494 | 1.33833084 |
| 40 | PKN2 | 1.28727216 |
| 41 | PRKCH | 1.28381655 |
| 42 | ERN1 | 1.28314624 |
| 43 | PDGFRA | 1.23604294 |
| 44 | MAP3K13 | 1.22572727 |
| 45 | MAP3K7 | 1.21166146 |
| 46 | SGK3 | 1.20105381 |
| 47 | PLK2 | 1.15991831 |
| 48 | WNK1 | 1.15954020 |
| 49 | RET | 1.14603140 |
| 50 | NUAK1 | 1.13199510 |
| 51 | MINK1 | 1.11472012 |
| 52 | CAMK1G | 1.10930529 |
| 53 | RIPK1 | 1.10494723 |
| 54 | ERBB4 | 1.10070711 |
| 55 | LMTK2 | 1.08854939 |
| 56 | FER | 1.07507172 |
| 57 | PHKG2 | 1.05532236 |
| 58 | PHKG1 | 1.05532236 |
| 59 | NLK | 1.05210382 |
| 60 | STK38 | 1.02557770 |
| 61 | PTK6 | 1.01112850 |
| 62 | PINK1 | 0.99120046 |
| 63 | SGK2 | 0.97568771 |
| 64 | BRSK2 | 0.96949870 |
| 65 | MST1R | 0.95938041 |
| 66 | ZAK | 0.95325476 |
| 67 | MKNK2 | 0.94907564 |
| 68 | STK3 | 0.92932480 |
| 69 | PDPK1 | 0.92071209 |
| 70 | LATS1 | 0.90469937 |
| 71 | MARK1 | 0.89802530 |
| 72 | PDK4 | 0.89706072 |
| 73 | PDK3 | 0.89706072 |
| 74 | CDK5 | 0.88670280 |
| 75 | EPHA3 | 0.88128056 |
| 76 | CAMK1D | 0.87642628 |
| 77 | EPHB1 | 0.87245379 |
| 78 | TGFBR1 | 0.87184316 |
| 79 | MET | 0.85034069 |
| 80 | DDR2 | 0.84979302 |
| 81 | CAMKK2 | 0.84515466 |
| 82 | CSNK1G1 | 0.84327186 |
| 83 | TRIM28 | 0.83770428 |
| 84 | CSNK1A1L | 0.82045901 |
| 85 | TRPM7 | 0.80358151 |
| 86 | STK24 | 0.79849504 |
| 87 | PDK1 | 0.77137429 |
| 88 | NTRK2 | 0.76084746 |
| 89 | ADRBK1 | 0.75059151 |
| 90 | JAK1 | 0.73082405 |
| 91 | PRKCG | 0.72565554 |
| 92 | PTK2 | 0.72178305 |
| 93 | PTK2B | 0.71242696 |
| 94 | MAP2K1 | 0.70621148 |
| 95 | MAP2K7 | 0.69996430 |
| 96 | CAMK2A | 0.69783093 |
| 97 | FLT3 | 0.69531047 |
| 98 | PRKCZ | 0.69325275 |
| 99 | CAMK2G | 0.68746992 |
| 100 | EIF2AK3 | 0.68340895 |
| 101 | KSR1 | 0.68095690 |
| 102 | SGK1 | 0.67311163 |
| 103 | PRKAA2 | 0.66926509 |
| 104 | TTN | 0.66579542 |
| 105 | CAMK2B | 0.65250361 |
| 106 | TYRO3 | 0.63789951 |
| 107 | CSNK1G2 | 0.63782311 |
| 108 | STK11 | 0.63303886 |
| 109 | JAK2 | 0.63296485 |
| 110 | MST4 | 0.61760697 |
| 111 | PRKD1 | 0.61475401 |
| 112 | MAPK12 | 0.60076898 |
| 113 | TXK | 0.59349499 |
| 114 | PRKAA1 | 0.58268855 |
| 115 | ERBB2 | 0.58246397 |
| 116 | PNCK | 0.55811676 |
| 117 | MUSK | 0.55655196 |
| 118 | BMX | 0.55379064 |
| 119 | PDK2 | 0.54989752 |
| 120 | PRKCE | 0.54860395 |
| 121 | PRKACG | 0.54804656 |
| 122 | TAOK3 | 0.54762282 |
| 123 | PDGFRB | 0.54139933 |
| 124 | FGFR3 | 0.53714888 |
| 125 | CSNK1G3 | 0.53434851 |
| 126 | CAMK2D | 0.52456213 |
| 127 | PKN1 | 0.51766021 |
| 128 | PRKCQ | 0.51279682 |
| 129 | MAPK11 | 0.51195426 |
| 130 | MYLK | 0.50525335 |
| 131 | MKNK1 | 0.50481713 |
| 132 | NEK9 | 0.50230587 |
| 133 | MAP3K1 | 0.50162252 |
| 134 | TIE1 | 0.49938602 |
| 135 | GSK3A | 0.48846746 |
| 136 | PIK3CG | 0.45927394 |
| 137 | FYN | 0.45363290 |
| 138 | PIK3CA | 0.44453489 |
| 139 | RPS6KA3 | 0.43933590 |
| 140 | FGFR1 | 0.43829879 |
| 141 | DYRK1A | 0.39117902 |
| 142 | PRKACA | 0.38376692 |
| 143 | NEK6 | 0.37113268 |
| 144 | CSNK1D | 0.35915883 |
| 145 | CSNK1A1 | 0.34829938 |
| 146 | RPS6KB1 | 0.34673001 |
| 147 | BMPR2 | 0.33511926 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 4.10472181 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.27041083 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.84972428 |
| 4 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.53448918 |
| 5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.44576928 |
| 6 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.42931801 |
| 7 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.41002533 |
| 8 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.34564763 |
| 9 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.33615328 |
| 10 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.16399024 |
| 11 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.16386327 |
| 12 | Phototransduction_Homo sapiens_hsa04744 | 2.14812238 |
| 13 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.12203327 |
| 14 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.92887189 |
| 15 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.87676566 |
| 16 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.79047633 |
| 17 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.78305395 |
| 18 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.77630564 |
| 19 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.77415542 |
| 20 | Bile secretion_Homo sapiens_hsa04976 | 1.74959857 |
| 21 | Peroxisome_Homo sapiens_hsa04146 | 1.66720446 |
| 22 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.65693477 |
| 23 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.64745705 |
| 24 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.59245650 |
| 25 | Circadian rhythm_Homo sapiens_hsa04710 | 1.55791108 |
| 26 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.52962995 |
| 27 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.48757336 |
| 28 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.48026400 |
| 29 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.46277287 |
| 30 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.45852282 |
| 31 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.41765699 |
| 32 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.40809600 |
| 33 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.40806475 |
| 34 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.40740358 |
| 35 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.38141691 |
| 36 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.35681366 |
| 37 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.32246514 |
| 38 | Histidine metabolism_Homo sapiens_hsa00340 | 1.23977976 |
| 39 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.22082279 |
| 40 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.18017595 |
| 41 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.17828209 |
| 42 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.16748498 |
| 43 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.16462462 |
| 44 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.15597119 |
| 45 | Protein export_Homo sapiens_hsa03060 | 1.13352146 |
| 46 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.12835167 |
| 47 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.10440717 |
| 48 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.04077577 |
| 49 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.03618091 |
| 50 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.01902819 |
| 51 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.98920927 |
| 52 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.97693498 |
| 53 | Long-term depression_Homo sapiens_hsa04730 | 0.97286456 |
| 54 | Mineral absorption_Homo sapiens_hsa04978 | 0.96987172 |
| 55 | ABC transporters_Homo sapiens_hsa02010 | 0.96175958 |
| 56 | Carbon metabolism_Homo sapiens_hsa01200 | 0.95680986 |
| 57 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.95376745 |
| 58 | Retinol metabolism_Homo sapiens_hsa00830 | 0.94575674 |
| 59 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.91402217 |
| 60 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.91293802 |
| 61 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.91082753 |
| 62 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.90360862 |
| 63 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.83812580 |
| 64 | GABAergic synapse_Homo sapiens_hsa04727 | 0.83319864 |
| 65 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.82688068 |
| 66 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.80793198 |
| 67 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.80527654 |
| 68 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.79704362 |
| 69 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.77339560 |
| 70 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.75454545 |
| 71 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.74180633 |
| 72 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.73916733 |
| 73 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.72858826 |
| 74 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.72789744 |
| 75 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.72364372 |
| 76 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.71912859 |
| 77 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.71375798 |
| 78 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.70187688 |
| 79 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.68680377 |
| 80 | Axon guidance_Homo sapiens_hsa04360 | 0.67888909 |
| 81 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.67032145 |
| 82 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.65297508 |
| 83 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.65159456 |
| 84 | Lysine degradation_Homo sapiens_hsa00310 | 0.64774846 |
| 85 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.64674371 |
| 86 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.63430077 |
| 87 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.61590325 |
| 88 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.61083199 |
| 89 | Nicotine addiction_Homo sapiens_hsa05033 | 0.59998070 |
| 90 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.59711340 |
| 91 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.59516580 |
| 92 | Insulin secretion_Homo sapiens_hsa04911 | 0.57764558 |
| 93 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.56463425 |
| 94 | Basal transcription factors_Homo sapiens_hsa03022 | 0.54348202 |
| 95 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.53962562 |
| 96 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.53959888 |
| 97 | Salivary secretion_Homo sapiens_hsa04970 | 0.53769766 |
| 98 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.53569439 |
| 99 | Circadian entrainment_Homo sapiens_hsa04713 | 0.52833069 |
| 100 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.52826114 |
| 101 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.52376894 |
| 102 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.51116295 |
| 103 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.50943230 |
| 104 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.49218407 |
| 105 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.48796098 |
| 106 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.48663959 |
| 107 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.48322268 |
| 108 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.47900339 |
| 109 | Insulin resistance_Homo sapiens_hsa04931 | 0.46608389 |
| 110 | Long-term potentiation_Homo sapiens_hsa04720 | 0.45637123 |
| 111 | Renin secretion_Homo sapiens_hsa04924 | 0.45435158 |
| 112 | Morphine addiction_Homo sapiens_hsa05032 | 0.45177446 |
| 113 | Tight junction_Homo sapiens_hsa04530 | 0.44370078 |
| 114 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.42917717 |
| 115 | Prion diseases_Homo sapiens_hsa05020 | 0.42899942 |
| 116 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.42071215 |
| 117 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.41526121 |
| 118 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.40353442 |
| 119 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.40082893 |
| 120 | Olfactory transduction_Homo sapiens_hsa04740 | 0.38984727 |
| 121 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.38745528 |
| 122 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.33156946 |
| 123 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.33020371 |
| 124 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.32700253 |
| 125 | Cocaine addiction_Homo sapiens_hsa05030 | 0.31318337 |
| 126 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.31240538 |
| 127 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.28441056 |
| 128 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.28295657 |
| 129 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.27341527 |
| 130 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.26856466 |
| 131 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.26325220 |
| 132 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.24718078 |
| 133 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.24638806 |
| 134 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.21232055 |
| 135 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.21099337 |
| 136 | Taste transduction_Homo sapiens_hsa04742 | 0.20730335 |
| 137 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.19491811 |

